Baird Financial Group, Inc. Vaccitech PLC Transaction History
Baird Financial Group, Inc.
- $47.6 Billion
- Q2 2024
A detailed history of Baird Financial Group, Inc. transactions in Vaccitech PLC stock. As of the latest transaction made, Baird Financial Group, Inc. holds 267,705 shares of VACC stock, worth $912,874. This represents 0.0% of its overall portfolio holdings.
Number of Shares
267,705
Previous 167,705
59.63%
Holding current value
$912,874
Previous $571,000
59.72%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VACC
# of Institutions
20Shares Held
15.1MCall Options Held
0Put Options Held
0-
M&G PLC London, X05.2MShares$17.7 Million0.02% of portfolio
-
M&G Investment Management LTD London, X05.2MShares$17.7 Million0.07% of portfolio
-
Alphabet Inc. Mountain View, CA1.51MShares$5.16 Million0.32% of portfolio
-
Sc China Holding LTD N/A, K31.42MShares$4.84 Million0.17% of portfolio
-
Dc Funds, LP Mclean, VA642KShares$2.19 Million29.94% of portfolio
About Vaccitech plc
- Ticker VACC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,216,200
- Market Cap $127M
- Description
- Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...